{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:07:36Z","timestamp":1774638456237,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jcf.2021.11.015","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T07:51:09Z","timestamp":1639986669000},"page":"230-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study"],"prefix":"10.1016","volume":"21","author":[{"given":"Marilisa","family":"Baldissera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Lewindon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise E.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter F.","family":"Hartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Mattiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jcf.2021.11.015_bib0001","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0002","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2016.03.041","article-title":"Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis","volume":"14","author":"Stonebraker","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2021.11.015_bib0003","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0000000000001676","article-title":"Cystic Fibrosis-related Liver Disease: research Challenges and Future Perspectives","volume":"65","author":"Debray","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2021.11.015_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep.24014","article-title":"Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy","volume":"53","author":"Lewindon","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.29217","article-title":"Adult-onset cystic fibrosis liver disease: diagnosis and characterization of an underappreciated entity","volume":"66","author":"Koh","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0007","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCP.0000000000000428","article-title":"Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease","volume":"23","author":"Van de Peppel","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2021.11.015_bib0008","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.30255","article-title":"Liver Disease in Cystic Fibrosis: illuminating the Black Box","volume":"69","author":"Colombo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0009","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MPG.0000000000002694","article-title":"Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities","volume":"70","author":"Singh","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2021.11.015_bib0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcf.2018.11.009","article-title":"Cirrhosis associated with decreased survival and a 10-year lower median age at death of cystic fibrosis patients in the Netherlands","volume":"18","author":"Pals","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1089-3261(02)00009-0","article-title":"Scoring of chronic hepatitis","volume":"6","author":"Scheuer","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jcf.2021.11.015_bib0013","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.hep.2003.10.010","article-title":"Liver biopsy size matters in chronic hepatitis: bigger is better","volume":"38","author":"Scheuer","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0014","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic Fibrosis Liver Disease: outcomes and Risk Factors in a Large Cohort of French Patients","volume":"69","author":"Bo\u00eblle","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jcf.2021.11.015_bib0016","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2021.11.015_bib0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/archdischild-2013-304159","article-title":"Cholestasis and meconium ileus in infants with cystic fibrosis and their clinical outcomes","volume":"99","author":"Leeuwen","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2021.11.015_bib0018","article-title":"Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations","author":"Tennant","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jcf.2021.11.015_bib0019","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/EDE.0b013e318225c2be","article-title":"A graphical tool for analyzing causal diagrams","volume":"22","author":"Textor","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.jcf.2021.11.015_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jcf.2021.11.015_bib0021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.jcf.2021.11.015_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12688\/hrbopenres.13065.1","article-title":"The impact of liver disease on mortality in cystic fibrosis - a systematic review protocol","volume":"3","author":"Sasame","year":"2020","journal-title":"HRB Open Res"},{"key":"10.1016\/j.jcf.2021.11.015_bib0023","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCP.0000000000000428","article-title":"Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease","volume":"23","author":"van de Peppel","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2021.11.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012056.pub2","article-title":"Interventions for preventing and managing advanced liver disease in cystic fibrosis","author":"Palaniappan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2021.11.015_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000001728","article-title":"Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis","volume":"66","author":"Ye","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2021.11.015_bib0026","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0000000000001676","article-title":"Cystic Fibrosis\u2013related Liver Disease","volume":"65","author":"Debray","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2021.11.015_bib0028","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2014.05.013","article-title":"Outcome in patients with cystic fibrosis liver disease","volume":"14","author":"Rowland","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0029","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2011.03.028","article-title":"Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation","volume":"55","author":"Chryssostalis","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2021.11.015_bib0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5001\/omj.2019.90","article-title":"Cystic Fibrosis Liver Disease: know More","volume":"34","author":"Al Sinani","year":"2019","journal-title":"Oman Med J"},{"key":"10.1016\/j.jcf.2021.11.015_bib0032","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcf.2017.03.006","article-title":"Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension","volume":"16","author":"Witters","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0033","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1183\/09031936.00119714","article-title":"A contemporary survival analysis of individuals with cystic fibrosis: a cohort study","volume":"45","author":"Stephenson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2021.11.015_bib0034","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcf.2017.11.019","article-title":"Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: a longitudinal study using UK patient registry data","volume":"17","author":"Keogh","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.11.015_bib0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321021561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321021561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:47:01Z","timestamp":1761601621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199321021561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1569199321021561"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2021.11.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2021.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}